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Nomenclature 
NS - Navicular Syndrome 
P2 - Middle or Second Phalanx 
P3 - Third or Distal Pahlanx 
DDFT- Deep Digital Flexor Tendon 
NSAIDs - Non-steroidal Anti-inflammatory Derivatives 
DIP J - Distal Interphalaangeal or Coffin Joint 
%BWF - Percent Body Weight of Force 
LFL -Forelimb Generating the Lower Baseline %BWF 
CFL - Forelimb Generating the Higher Baseline %BWF 
TA - Triamcinolone Acetonide 
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INTRODUCTION 
Navicular syndrome (NS) is a poorly understood, incurable degenerative 
condition of the distal sesamoid bone and/or its supporting soft tissue structures. I-4 It 
is a common source of pain resulting in lameness that hinders the performance of 
many horses regardless of discipline.5 Diagnosis of NS is based on many factors but 
is not always straightforward. Most often, a subjective lameness assessment is 
utilized not only for determining baseline lameness, but also for response to the 
treatment modality employed to manage the condition. Subjective lameness 
assessment is not always standardized and is dependent on the opinion and experience 
of the examiner. With the development of quantitative gait analysis technologies such 
as the force plate, equine lameness can now be evaluated in an objective fashion.6-10 
The first two chapters review the anatomy of the equine navicular apparatus 
and provide a literature review describing the etiology, clinical presentation, 
diagnosis, and treatments used to manage NS in the horse. Reports utilizing force 
plate technology in the diagnoses of equine lameness are also presented. 
The remainder of the text describes a clinical investigation aimed at 
objectively and quantitatively evaluating lameness following initiation of 
com bi nations of three commonly used treatment modalities for NS using force plate 
technology. The treatment modalities evaluated were heel elevation shoeing alone, 
heel elevation shoeing in conjunction with phenylbutazone, heel elevation shoeing in 
conjunction with distal interphalangeal joint (DIPJ) corticosteroid injection and all 
1 
three in combination. Our hypothesis was that the described method of heel elevation 
shoeing would increase mean % body weight of force (%BWF) applied to the 
forelimbs of horses suffering from NS. We also suspected that the addition of 
phenylbutazone and/or DIPJ corticosteroid injection to this shoeing technique would 




The distal sesamoid bone or navicular bone of the equine is a small boat 
shaped bone located in the palmar/plantar distal aspect of the foot. It is anatomically 
positioned in such a way that its dorsal surface articulates with the distal end of the 
middle phalanx (P2) while the distal most extent is connected to the distal phalanx 
(P3) by the impar ligament. The palmar/planter (flexor) surface of the navicular bone 
is bordered by the tendon of the deep digital flexor muscle group (DDFT) as it 
courses to its insertion on P3. Between the navicular bone and the DDFT lies the 
navicular bursa. This is a fluid filled synovial structure which provides a gliding 
surface for the DDFT across the navicular bone when the horse is in motion. The 
suspensory or collateral ligaments of the navicular bone originate from the distal 
aspect of the first phalanx and insert on their respective medial or lateral border of the 
. navicular bone. These soft tissue structures along with the navicular bone comprise 
the navicular apparatus. Disease of any one component of the navicular apparatus can 






Navicular syndrome, also termed navicular disease, naviculitis, or 
podotrochleosis, was first reported in 1752. 11 This condition can be defined as a 
chronic forelimb lameness attributed to pain originating from one, some or all of the 
structures comprising the navicular apparatus. Although it is a progressive, 
degenerative condition for which there is no cure, many treatment modalities have 
been advocated attempting to manage this painful condition. 11-20 Thus, many horses 
affected by this disease process can be functionally sound and able to perform in 
equine activities. 
Etiology 
Many attempts to define the exact pathogenesis of navicular syndrome have 
been made, however, efforts to experimentally reproduce the disease have not been 
successful. 3 Therefore, all proposed etiologies remain speculative. Although the 
cause remains unclear, two main theories of pathogenesis have evolved. One is the 
theory of vascular compromise to and/or from the navicular region. This theory 
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Suggests that a lack of blood flow to the navicular region results in pain and 
ischemic damage to the navicular bone. The resorption of necrotic bone tissue leads 
to cystic lesions and subchondral sclerosis of the navicular bone. Alternatively, 
occluding venous return from the heel area of the foot results in venous congestion, 
increased bone marrow pressure and pain within the navicular bone. However, 
attempts to induce NS with various forms of vascular compromise have been 
unsuccessful and pathologic changes consistent with thrombosis and/or ischemia have 
not been observed.21•25 
The second theory of pathogenesis for NS involves abnormal biomechanical 
function or biomechanical trauma. 12•23 During motion, the DDFT compresses the 
navicular bone dorsally against P2 and P3. The amount of force exerted by this 
tendon is dependent on many factors including conformation, shoeing, body weight, 
and the speed at which the animal is traveling. 26 In most horses, the force exerted is 
within an acceptable range however, in horses with predisposing abnormalities, the 
force exerted can become excessive resulting in damage to the navicular apparatus. 1 
· Thus, poor conformation, improper trimming/shoeing, intense training or use, 
excessive body weight and genetics have all been implicated as predisposing factors 
to the development ofNS. 1•2•5•27 
Clinical Significance 
NS is one of the most common causes of forelimb lameness in performance 




The classic presentation of horses suffering from NS is a middle aged (8-14 
years) performance horse with a chronic bilateral forelimb lameness. 1•3•5•11 The owner 
many times will complain of a problem originating in the shoulder. 1 Lameness can 
range from mild to severe depending on the stage of disease. Lameness may worsen 
after exercise or trimming/shoeing and the horse may be observed pointing one foot 
consistently or alternating feet. Less commonly a horse will be presented with an 
acute onset of lameness. 
Diagnosis 
Prior to the mid l 980's, diagnosis of NS was routinely based on the clinical 
presentation classically consisting of bilateral forelimb lameness improved with 
palmar digital perineural or distal interphalangeal joint anesthesia. 12•28 However, 
many more lameness etiologies can be improved with these diagnostic techniques 
thus a more in depth examination is needed. Accurate clinical diagnosis of NS begins 
with a thorough history and physical examination. Abnormalities such as under-run 
heel, hoof asymmetry, increased digital pulse and distal interphalangeal joint effusion 









Hoof testers should be applied to the soles of both forelimbs. Pain is often 
but not always observed across the heel area.1•3•5•11• 27 
Following physical examination, a comprehensive lameness evaluation should 
be performed. Observation of the horse's gait at a trot on a firm surface is important. 
In some cases it may be difficult to observe lameness in the straightaway but turning 
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the horse in tight circles exacerbates the lameness.1•3•11•12.27 A number of distal limb 
flexion and extension tests have been employed to aid in the clinical diagnosis of NS 
although none are specific to the disease. 1•3•5•11•12.27 
Improvement in lameness by desensitization of the caudal heel area with 
palmar digital perineural anesthesia is seen in 90% of horses with NS. 1•3•5•11 Intra-
articular anesthesia of the distal interphalangeal joint can also alleviate pain 
originating from the navicular apparatus, 29 however neither of these techniques is 
specific. Perhaps the most specific analgesic technique for NS is local anesthesia of 
the navicular bursa.3•12•27 Although more specific, this technique is technically more 
challenging for the veterinarian and often omitted. 
Once the clinical diagnosis of NS is highly suspected, imaging of the area to 
confirm pathologic change is perfonned. Many imaging modalities have been 
utilized in the diagnosis of NS. By far the most common and most readily available 
to the majority of equine practitioners is conventional radiography. Others include 
ultrasonography, nuclear scintrigraphy, computed tomography and magnetic 
resonance imaging. 
Conventional radiography usually consists of lateromedial, dorsoproximal-
palmarodistal oblique and palmaroproximal-palmarodistal oblique projections. These 
three views allow visualization of the navicular bone in three different plains, 
however, the soft tissue structures cannot be evaluated. Therefore, radiographic 
imaging findings may not correlate with clinical findings. 30•31 Nuclear scintigraphy 
can also be misleading due to false positive and false negative results. 32 
Ultrasonography of the equine foot is limited by the poor acoustic window afforded 
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by the pal mar aspect of the foot. 3° Computed tomography provides high-detail 
tomographic images many times identifying osseous lesions not seen by conventional 
radiography and magnetic resonance imaging provides superior contrast for 
recognizing soft tissue lesions.30 However, closed computed tomography and 
magnetic resonance imaging scanners necessitate general anesthesia increasing risk to 
the patient and cost for the client.30 
Treatment Modalities 
Most equine practitioners agree that some type of corrective/therapeutic 
shoeing is the basis for treatment for NS and other treatment modalities should be 
used in conj unction. 1 Correction of any pre-existing hoof abnormalities i.e. hoof 
imbalance, is the first goal. 14 Several shoeing techniques have been employed 
attempting to improve lameness of horses with NS. The most common involves 
raising the hoof angle by elevating the heel. 12•14 Full bar and egg-bar shoes have also 
been advocated to provide extra support for the palmar aspect of the foot. 1•12 A rolled 
toe in conjunction with these shoe types serves to ease breakover. 1 Improvement has 
also been achieved with the natural balance shoe. 4 Unfortunately, one shoeing 
method has not been shown to be superior in all cases. 
Non-steroidal anti-inflammatory derivatives (NSAIDs), especially 
phenylbutazone, are the most common medications used to manage NS. 1•27•33 
NSAIDs may only be necessary to break the pain cycle while the horse adapts to 
corrective shoeing. However, some horses may require additional medication 
intermittently associated with performance/athletic events and severely lame horses 
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may need continuous therapy to maintain normal daily function. Traditionally, 
phenylbutazone has been thought to provide better musculoskeletal analgesia while 
flunixin meglumine has been considered better for visceral pain such as colic. 
However .. a recent study reported similar analgesic effects of either medication for 
horses with NS. 34 
Intra-synovial injection of corticosteroids has been widely used to treat equine 
lameness. Corticosteroids have been shown to reduce volume and increase viscosity 
of synovial fluid and to stabilize chondroblasts.35 However, long term corticosteroid 
therapy can have detrimental effects on articular cartilage and reduces hyaluronic acid 
synthesis. 35 Although the distal interphalangeal joint (DIPJ) and the navicular bursa 
have no direct communication,36 administration oflocal anesthetic solution into the 
navicular bursa can alleviate lameness originating from the DIPJ 20 minuets 
following injection,37 and substances injected into the DIPJ have been found in 
navicular bursa fluid and synovium and in the medullary cavity of the navicular 
b 29 38 Th c. • • • f · 'd . .th f th ·a1 one. · ere1ore, mJect1on o cort1costero1 s mto e1 er o ese synov1 
structures has been advocated to manage NS. 18 
Palmar digital neurectomy has been advocated in an attempt to allow horses 
diagnosed with navicular syndrome to return to athletic soundness. 20 Numerous 
surgical neurectomy techniques have been described including guillotine transaction, 
perineural capping, carbon dioxide laser transection, and carbon dioxide laser 
coagulation each attempting to decrease the incidence of painful neuroma formation 
and increase time before reinervation. 12 One study has shown sharp guillotine 
transaction less likely to result in painful neuromas. 39 
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Equine Lameness Analysis 
Subjective 
Traditionally, equine lameness assessment has been based on the subjective 
opinion of the examiner. Thus, differing opinions as to the severity of the lameness 
are often made depending on the experience of the examiner. 40 Uniform lameness 
grading standards are very important not only for record keeping, but allow different 
examiners to evaluate an animal for improvement. Several lameness grading scales 
have been developed in an attempt to standardize subjective lameness assessment.41•42 
The American Association of Equine Practitioners has provided a standardized 5-
point scale
41 in an attempt to develop a universal standard, but even this scale is 
subject to the opinion of the examiner. 
Objective 




10 The force plate is able to record the maximal vertical ground reaction 
force generated by each limb as it strikes the plate with the horse in motion. Peak 
vertical ground reaction force has been found to be inversely correlated to the degree 
of lameness when normalized to body weight.6•7 A recent study concluded that the 
mean percent body weight of force (%BWF) generated by the forelimbs of horses 
diagnosed with NS did not change day-to-day or week-to-week over a three week 
period. 
15 
Therefore, degree of quantitative lameness of horses with NS does not 
change over a short period of time. 
10 
CHAPTER III. 
MATERIALS AND METHODS 
Inclusion Criteria 
Horses presented to the Oklahoma State University Boren Veterinary Medical 
Teaching Hospital for forelimb lameness evaluation and displaying clinical and 
radiographic evidence of NS were considered for this study. Clinical evidence of NS 
was defined as horses displaying bilateral forelimb heel area pain with hoof testers 
accompanied by bilateral forelimb lameness improved with palmar digital perineural 
anesthesia. Initial lameness was evaluated subjectively using the American 
Association of Equine Practitioners (AAEP) five point scale.41 Standard navicular 
radiographic studies (lateromedial, 60° dorsoproximal-palmarodistal oblique, and 45° 
palmaroproximal-palmarodistal oblique) of both forelimbs were obtained and each 
navicular bone was scored by a board certified veterinary radiologist on a O to 4 
scale.
31 
Any horse receiving a combined score of2 or more was considered to have 
radiographic evidence of NS. Animals with dispositions unsuitable for shoeing or 
force plate data collection were excluded. Participation in the research trial was 
requested from the owner of any animal meeting the above selection criteria. A 
signed client consent form was obtained and approval from the Oklahoma State 
University Institutional Animal Care and Use Committee was granted. 
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Animals 
Twelve horses (eight geldings and four mares) with a mean age of 10 (STD 
3.9) years were included in this study. The duration oflameness according to the 
owner ranged from one month to two years. 
Quantative Assessment of Force 
The peak vertical ground reaction force generated by the forelimbs was 
measured by trotting each horse across a floor-mounted piezo-electric force plate8 at 
2.50-2.90 mis. This velocity was measured using a millisecond timer and two 
photoelectric switchesb three meters apart. The peak vertical ground reaction force 
was measured initially in Newtons, converted to kg of force, and finally normalized 
to body weight by the Bioware softwarec. This value, o/oBWF, was then used for 
comparison between treatments. Six valid strikes to the force plate were averaged to 
obtain the mean %B WF generated by each forelimb at each data collection session . 
. Experimental Design 
Data for each forelimb was collected at six different sessions. At the first 
session, the baseline mean %BWF was obtained prior to any treatment. At this data 
collection session, the forelimb generating the lower o/oBWF was denoted the lame 
forelimb (LFL) and the forelimb generating the higher o/oBWF was denoted the 
contralateral forelimb (CFL) for the duration of the study. All four hooves were then 
trimmed and balanced. Wide web aluminum three-degree wedge horseshoesd were 
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applied to the fore feet and steel flat horseshoese were applied to the hind feet with 
nails by an experienced farrier. Measurements reveal that these aluminum shoes are 
57% lighter and have a 27% increase in surface area compared to a comparable flat 
steel shoec. Special emphasis was placed on the heel area so that the bar of the shoe 
extended 3-4 mm abaxial to the hoof wall caudal to the last nail and 10-12 mm 
beyond the caudal most extent of the heel. 
The second data collection session occurred 24 hours post-shoeing to evaluate 
the immediate response to heel elevation. An adaptation period of two weeks was 
chosen to evaluate the effects of heel elevation shoeing alone and therefore 14 days 
post-shoeing mean %BWF was recorded at the third data collection session. 
Subsequently, phenylbutazone (4.4 mg/kg [2 mg/lb], IV, q 12h) was administered for 
five treatments. This is considered the maximum short term dose of 
phenylbutazone.44 Two hours following the last treatment, the mean %BWF was 
recorded at the fourth session measuring the combined effect of shoes and 
phenylbutazone. Immediately following the fourth data collection session, the DIPJ 
of the LFL was injected with 6mg of triamcinolone acetonide(TA)' The DIPJ 
injection was given a period of two weeks before evaluation and the mean %BWF 
was recorded at the fifth session measuring the combined effect of heel elevation 
shoeing and DIP J TA injection. Although intra-articular injection of corticosteroids 
into the DIP J is routinely performed bilaterally, only the DIPJ of the LFL was 
injected for this study. Since the horses were given a two week period before 
response to the DIPJ TA injection was evaluated, any significant change in %BWF 
could have been attributed to the additional shoeing adaptation time rather than 
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response to the TA injection. Therefore, only one joint was injected in order to 
identify which treatment modality was responsible for any change in %BWF. 
Phenylbutazone(4.4mg/kg [2 mg/lb], IV, q 12h) was again administered for five 
treatments and two hours following the last injection mean %BWF was recorded at 
the sixth and final session measuring the effect of all three treatment modalities in 
combination. A recent study concluded that the %BWF generated by the forelimbs of 
horses diagnosed with NS did not change day-to-day or week-to-week over a three 
week period.'0 Therefore, the degree of quantitative lameness of horses with NS is 
not expected to change over the duration of the described experiment. 
Data analysis 
Since NS is a bilateral condition, data for each forelimb were collected and 
analyzed separately for improvement in the respective limb. Data collected 24 hours 
and 14 days post-heel elevation shoeing were compared to baseline data for 
significant change in mean %BWF. Statistical analysis was performed using a 
repeated measures analysis of variance techniques separately for each forelimb on a 
sample population and individual horse level with PC SAS Version 8.2.g Effects of 
each treatment were analyzed using ANOV A with the PROC MIXED method in 
SAS. Effects of treatment were analyzed using a LSMEANS statement. Effects were 





Average baseline and treatment mean %BWF of the sample population is 
summarized in Fig. 1. Twenty-four hours following the application of heel elevation 
shoes, the average mean %BWF did not significantly change for either forelimb. 
However, following a 14 day adaptation period, heel elevation shoeing significantly 
increased average %BWF over baseline for both limbs. The addition of 
phenylbutazone to heel elevation shoeing significantly increased average mean 
%BWF of the LFL (p < 0.0001) and increased the mean %BWF of the CFL, however 
this was not statistically significant from fourteen days post-heel elevation shoeing 
alone (p < 0.25). When compared to data collected fourteen days post-shoeing, the 
addition of DIPJ TA injection of the LFL to heel elevation shoeing failed to show 
significant improvement in the average mean %BWF of either limb from shoeing 
alone (p = 0.29 for LFL and 0.88 for CFL). When compared to fourteen day post-
shoeing data, all three treatment modalities in combination provided similar results to 
shoeing in combination with phenylbutazone with a significant increase of average 
mean %BWF of the LFL (p < 0.0001). The CFL again increased but was not 

















Baseline 24hPS 14dPS S/PBZ S/JI S/JVPBZ 
Fig. 1 Population Results - Average force expressed as mean percentage of body weight (%BWF) 
fotRl 
~ 
generated by the forelimbs of twelve horses with navicular syndrome prior to and following five 
treatment modalities. 24hPS::: 24 hours post heel elevation shoeing; 14dPS = 14 days post heel 
elevation shoeing; S/PBZ::: heel elevation shoeing in combination with phenylbutazone; S/JI = heel 
elevation shoeing in combination with distal interphalangeal joint corticosteroid injection; S/JI/PBZ = 
heel elevation shoeing in combination with both distal interphalangealjoint corticosteroid injection and 
phenylbutazone. LFL - Forelimb generating the lower baseline mean %BWF. CFL - Contralateral 
Forelimb. Values with the same letter designation (a-d & A-C) are not statistically significant from 
each other. n = 12. 
· Individual results 
Twenty-four hours following the application of heel elevation shoes, significant 
improvement in the mean %BWF applied to the LFL of three horses and the CFL of 
three horses. For each limb, nine horses failed to show improvement or worsened 24 
hours following application of the therapeutic shoes. However, following a 14 day 
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adaptation period, heel elevation shoeing significantly increased mean %BWF over 
baseline of the LFL in nine of the horses. Six horses significantly increased average 
%BWF of the CFL. When compared to shoeing alone, the addition ofphenylbutazone 
further increased mean %BWF of the LFL in eight of the horses while increasing the 
mean %BWF of the CFL in five horses. The addition ofDIPJ TA injection of the 
LFL to heel elevation shoeing significantly increases the average mean %BWF of the 
LFL over shoeing alone in six horses while three horses improved %BWF of the 
CFL. When compared to fourteen day post-shoeing data, all three treatment 
modalities in combination resulted in a significant increase of average mean %BWF 




The results of this study indicate that the described method of three degree 
heel elevation shoeing alone and in combination with systemic administration of 
phenylbutazone may quantitatively decrease lameness in horses suffering from NS. 
Although not statically significant, the addition of DIP J injection of TA to three 
degree heel elevation shoeing may offer further quantitative improvement in lameness 
in individual horses. However, some horses may be refractory to these treatment 
methods and require other modalities such as alternate therapeutic shoeing techniques 




Inappropriate or inadequate foot care is a common finding in horses with NS. 
Long toes, under-run heels and hoof imbalance can put excess strain on the navicular 
apparatus. Shoes that are too small and/or shoes that do not extend to or beyond the 
caudal most extent of the heel do not provide appropriate support. 12 The shoes used 
in this study were fitted in such a way to provide maximum support to the heel. The 
wide web provides additional surface area decreases force/unit area of ground contact 
and the reduced weight serves to decrease inertial kinetic forces on the distal limb. 
Although only three of the twelve horses improved 24 hours following the described 
method of therapeutic shoeing, the majority of the horses in this study significantly 
improved %8 WF of their forelimbs indicating improvement in lameness following 
the 14 day adaptation period. This supports previous reports of an adaptation period 
necessary for corrective shoeing to relieve the inciting painful stimuli. 
Results of this clinical trial indicate that horses suffering from NS may 
significantly increase the mean %BWF generated by their forelimbs fourteen days 
after being shod in the described fashion. These results support the biomechanical 
theory of pathogenesis, and heel elevation serves to decrease pain in the foot by 
. reducing the pressure applied on the navicular bone. In this study, some of the horses 
did not change or significantly decreased mean %BWF with this shoeing technique. 
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This is consistent with other corrective shoeing methods, however a longer 
adaptation period may be necessary to fully recognize the benefit of this heel 
elevation shoeing technique.1' 13'14 Other corrective shoeing techniques for NS that do 
not utilize the heel-elevation principle, such as egg-bars, natural balance, etc., may 
have benefited these horses, however, horses shod with flat shoes have an increased 
maximal force exerted on the navicular bone by the DDFT compared to unshod 
45 46 
horses. · 
The addition of phenylbutazone to the described method of shoeing further 
improved the mean ¾BWF of eight horses. The musculoskeletal analgesic properties 
ofNSAIDs are well documented. The dose of phenylbutazone used in this study (4.4 
mg/kg [2mg/lb] q 12 h) was approximately 2g for a 500kg horse. This dose was 
chosen to provide maximum anti-inflammatory response in a short time period 
similar to the administration of phenylbutazone in association with athletic 
performance however, one report suggests a lower dose (4.4 mg/kg [2mg/1b] q 24h) 
may be as effective and reduces the potential for toxicity.
47 
Although the average quantitative lameness data obtained from the twelve 
horses in this study demonstrated no significant difference from shoeing alone, an 
increase in ¾BWF of the LFL was noted in six of the twelve horses 14 days 
following injection of TA. However the six other horses either demonstrated no 
change or a dccre0sc the mean ¾BWF of the LFL following injection. One report 
advocates injection of corticosteroids \\1 combination with hyaluronate directly into 
the NB of horses refractory to other treatments. 18 Hyaluronate in combination with 
20 
corticosteroids has been shown to be more beneficial than corticosteroids alone
35 
and 
may have further benefited the horses in this study. 
Therapeutic shoeing in some fashion is considered the basis of treatment for 
NS by many practitioners. This experiment was conducted in such a way that all 
treatment modalities included and therefore was dependent therapeutic shoeing, 
however, changing the sequence of which the different treatment modalities were 
applied may have provided different results. For instance, phenylbutazone or DIPJ 
TA injection alone or the combination of these two treatments without the addition of 
therapeutic shoeing may have shown a quantitative change in ¾BWF of the horses. 
In addition, combinations of other therapeutic shoeing m odalities and other medical 
and surgical treatments may alter the quantitative lameness of horses with NS. 
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Footnotes 
a. Piezoelectric Biomechanics Force Plate System Type 9287920311, Kistler, 
Amherst, NY 14228 
b. Infrared Photoelectric Sensor Model #49-551A, Radioshack Corporation, Fort 
Worth, TX 76102 
c. Bioware Ver. 3.22 Type 2812Al-3, Kistler, Amherst, NY 14228 
d. Elite Competition Shoe- 3-degree wedge, Victory Racing Plate Company, 
Baltimore, MD 21237 
e. St. Croix Lite, St. Croix Forage, Forest Lake, MN 55025 
f. Vetalog 6 mg/ml, Ft Dodge Animal Health, Ft Dodge, IA 50501 
. g. PC SAS Version 8.2, SAS Institute, Cary, NC 27513 
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